Skip to main content

Rsv vaccine, pref a-pref b, recombinant Disease Interactions

There is 1 disease interaction with rsv vaccine, pref a-pref b, recombinant.

Moderate

Respiratory syncytial virus recombinant vaccine (applies to rsv vaccine, pref a-pref b, recombinant) immunodeficiency

Moderate Potential Hazard, Moderate plausibility.

Immunocompromised individuals, including those receiving immunosuppressive therapy, may have a diminished immune response to the respiratory syncytial virus vaccine.

References

  1. "Product Information. Abrysvo (RSV vaccine, preF A-preF B, recombinant)." Pfizer U.S. Pharmaceuticals Group

Rsv vaccine, pref a-pref b, recombinant drug interactions

There are 289 drug interactions with rsv vaccine, pref a-pref b, recombinant.

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer